NCT00336531View on ClinicalTrials.gov

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

October 31, 2008

Conditions
NeuroblastomaBrain TumorRetinoblastomaWilms TumorMycoses
Interventions
DRUG

itraconazole

2.5 mg/kg twice daily for the first two days --\> once daily

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00336531 - Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter